Original paper
Pancreastatin induces hepatic steatosis in type 2 diabetes by impeding mitochondrial functioning
Abstract
Mitochondrial dysfunction is among the key factors for the advancement of hepatic steatosis to NAFLD and NASH. Pancreastatin (PST: human ChgA250-301) is a dysglycemic hormone, previously reported to promote steatosis and inflammation in various animal models of metabolic disorders. Recently, we observed PST deregulates energy expenditure and mitochondrial functioning in perimenopausal rats. In the current study, we aimed to decipher the role of...
Paper Details
Title
Pancreastatin induces hepatic steatosis in type 2 diabetes by impeding mitochondrial functioning
Published Date
Nov 1, 2021
Journal
Volume
284
Pages
119905 - 119905
Citation AnalysisPro
You’ll need to upgrade your plan to Pro
Looking to understand the true influence of a researcher’s work across journals & affiliations?
- Scinapse’s Top 10 Citation Journals & Affiliations graph reveals the quality and authenticity of citations received by a paper.
- Discover whether citations have been inflated due to self-citations, or if citations include institutional bias.
Notes
History